MoneyWorks4Me

Marksans Pharma acquires entire stake in Access Healthcare

10 Jun 2022 Evaluate

Marksans Pharma has completed the acquisition of 100% stake in Access Healthcare for Medical Products based in Dubai, UAE. Earlier, in April 2022, the company had signed a share purchase agreement to acquire a 100% stake in Access Healthcare. This deal will enable Marksans to use the front-end sales and marketing infrastructure of Access Healthcare for marketing its products manufactured in the India, UK, and USA regions. It will bolster Marksans' presence in the Middle East and North African regions by leveraging Access Health's knowledge of local business cultures and access to a network of partners and distributors in those regions.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..